MALINDA INGRAM: Open Payments
NPI 1245276849 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 19 payments from 7 companies in 2025. Trend: 2023 $307 · 2024 $152 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $193 |
| MILLICENT US INC | 3 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $39 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Hologic Sales and Service, LLC | 1 | $32 |
| Exeltis, USA Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: Veozah, ACCRUFER, INTRAROSA, ACESSA PROVU SYSTEM, SLYND, LILETTA, FEMRING.
Industry payments across MS — which companies pay providers there.
